NantKwest (NK) News Today → You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad) Free NK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSpace Nk Promo Codestime.com - February 4 at 1:22 PMFrankie Bridge shares her new Space NK beauty buys including concealer people 'love'mirror.co.uk - August 13 at 7:35 PMPiper Sandler Downgrades ImmunityBio (IBRX)msn.com - May 13 at 2:34 AMNantKwest Inc (IBRX) Earnings Dates & Reportsinvesting.com - May 12 at 8:49 PMNK Cells Market Report | Research Across The World 2031marketwatch.com - May 10 at 1:16 PMNatural Killer Cell Therapy Market Size, Growth | Soaring Demand | 2023 - 2029marketwatch.com - March 9 at 4:09 AMNatural Killer Cell Therapy Market 2023 Statistics, Share Price, Growth Prospects, Industry Trends till 2028marketwatch.com - January 12 at 8:32 AMNK Cell Therapy Market Insights: Industry changing aspects, New Technologies and Forecast to 2025 | Market Growth Reportsmarketwatch.com - November 26 at 8:16 AMNatural Killer Cells Therapeutics Market 2022 : Top Manufacturers, Key Trends, Progression Status and Business Trends to 2027marketwatch.com - September 29 at 11:24 AMNatural Killer Cell Therapy Market 2022 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2026marketwatch.com - August 22 at 10:59 AMGlobal Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities - Yahoo Financefinance.yahoo.com - August 12 at 12:34 PMGlobal Engineered T Cells Market Report 2022-2027: Increasing Demand for Innovative Biopharmaceutical The - Benzingabenzinga.com - August 11 at 4:32 PMHarpoon Therapeutics Expands Leadership Team - Yahoo Financefinance.yahoo.com - July 6 at 9:33 AMCelldex (CLDX) Appoints Cheryl L. Cohen and Dr. Garry Neil to its Board - StreetInsider.comstreetinsider.com - June 18 at 9:22 PMCelldex Announces Two New Appointments to its Board of Directors - Yahoo Financefinance.yahoo.com - June 16 at 4:58 PMImmPACT Bio Names Sylvain Roy as Chief Technology Officer - PR Newswireprnewswire.com - May 13 at 12:31 AMRAPT Therapeutics Expands Leadership Team with Multiple Key Hires - Yahoo Financefinance.yahoo.com - May 4 at 2:59 PMRAPT Therapeutics Expands Leadership Team with Multiple Key Hires - Marketscreener.commarketscreener.com - May 4 at 9:58 AMList: the 17 Fastest-Growing Biotechs and Pharmas of 2021 - Business Insiderbusinessinsider.com - March 29 at 8:36 AMNatural Killer (NK) Cell Therapy Market Research Report 2022 - Comprehensive Insights about 100+ Companies and 185+ Pipeline Drugs - ResearchAndMarkets.com - Business Wirebusinesswire.com - March 10 at 7:17 PMBiotechs face cash crunch after stock market ‘bloodbath’ - Financial Timesft.com - February 10 at 2:45 AMBladder Cancer Disease Market Analysis Research Report 2021 - ResearchAndMarkets.com - Business Wirebusinesswire.com - January 29 at 1:50 PMImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing - Yahoo Financefinance.yahoo.com - December 20 at 9:55 AMAmbrx Biopharma Inc. Reports 1H 2021 Financial Results and Provides Corporate Update - Business Wirebusinesswire.com - October 29 at 7:20 AMGlobal Natural Killer Cell Therapies Pipeline Insight Report 2021: 100+ Companies and 140+ Pipeline Drugs - ResearchAndMarkets.com - Business Wirebusinesswire.com - October 20 at 12:45 AMFed. Circ. Removes Hyatt's Motives From Expert Fees Win - Law360law360.com - October 12 at 8:45 PMFed. Circ. Denies USPTO's Bid For Expert Fees From Inventor - Law360law360.com - August 18 at 10:31 PMFed Circ says inventor doesn't owe PTO's expert fees in patent appeal - Reutersreuters.com - August 18 at 5:30 PMAnalyzing Tattooed Chef's Unusual Options Activitybenzinga.com - August 13 at 8:38 AM Get NantKwest News Delivered to You Automatically Sign up to receive the latest news and ratings for NK and its competitors with MarketBeat's FREE daily newsletter. Email Address You’re invited: Biggest crypto event of 2024 (Ad)During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. NK Media Mentions By Week NK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NK News Sentiment▼0.000.53▲Average Medical News Sentiment NK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NK Articles This Week▼00▲NK Articles Average Week Get NantKwest News Delivered to You Automatically Sign up to receive the latest news and ratings for NK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NVAX News VALN News ALLO News MESO News FATE News PROK News PRME News EXAI News ALEC News HLVX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NK) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Perfect Storm” for GoldGold Safe ExchangeHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchUrgent alert: open this for a huge profit potentialTimothy SykesThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantKwest, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.